Bharat Immunological Biological Corporation Ltd vs Source Natural Foods Herbal Supplements Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 06, 2026

Key Highlights

The Latest Trading Price of Bharat Immunological & Biological Corporation Ltd is ₹ 17.3 as of 06 May 15:30 . The P/E Ratio of Bharat Immunological & Biological Corporation Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Source Natural Foods & Herbal Supplements Ltd changed from 28.2 on March 2021 to 46.2 on March 2025 . This represents a CAGR of 10.38% over 5 years The Market Cap of Bharat Immunological & Biological Corporation Ltd changed from ₹ 196.47 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of -100.00% over 5 yearsThe Market Cap of Source Natural Foods & Herbal Supplements Ltd changed from ₹ 95.27 crore on March 2021 to ₹ 133.98 crore on March 2025 . This represents a CAGR of 7.06% over 5 years The revenue of Bharat Immunological & Biological Corporation Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Source Natural Foods & Herbal Supplements Ltd for the Dec '25 is ₹ 20.3 crore as compare to the Sep '25 revenue of ₹ 16.95 crore. This represent the growth of 19.76% The ebitda of Bharat Immunological & Biological Corporation Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Source Natural Foods & Herbal Supplements Ltd for the Dec '25 is ₹ 1.53 crore as compare to the Sep '25 ebitda of ₹ 1.36 crore. This represent the growth of 12.5% The net profit of Bharat Immunological & Biological Corporation Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The net profit of Source Natural Foods & Herbal Supplements Ltd changed from ₹ 0.42 crore to ₹ 0.82 crore over 7 quarters. This represents a CAGR of 46.57% The Dividend Payout of Bharat Immunological & Biological Corporation Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Source Natural Foods & Herbal Supplements Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Bharat Immunological & Biological Corporation Ltd

The Bharat Immunologicals and Biologicals Corporation Limited (BIBCOL) is a Central Public Sector Unit, under the Department of Biotechnology, Ministry of Science and Technology.
BIBCOL was incorporated in 1989.
The Company is engaged in the manufacture of Oral Polio Vaccine (OPV) , Zinc Tablets and Diarehha management Kit and BIB Sweet Tablets. The company's manufacturing unit is located in Bulandshahr Dist., Uttar Pradesh.
BIBCL installed a plant of 100 mln units.
Commercial production of the OPV started from Jan'96. The company has received firm orders for supply of OPV from the Ministry of Health and Family Welfare, Government of India, for use in the national immunisation programme.

About Source Natural Foods & Herbal Supplements Ltd

Source Natural Foods &Herbal Supplements Limited was formerly incorporated as Inwinex Pharmaceuticals Limited in 1995.
The Company name was then changed from Inwinex Pharmaceuticals Limited to Source Natural Foods &Herbal Supplements Limited in 2011-12.
The Company engages in the pharmaceutical business in India.
It provides allopathic and ayurvedic formulations.
Its principal products include Organic Ashwagandha, Organic Triphala, and Organic Satavari Tablets. Company operates in the Ayurveda and herbal sphere which has been identified as one of the key sectors of growth and innovation for the Country.

FAQs for the comparison of Bharat Immunological & Biological Corporation Ltd and Source Natural Foods & Herbal Supplements Ltd

Which company has a larger market capitalization, Bharat Immunological & Biological Corporation Ltd or Source Natural Foods & Herbal Supplements Ltd?

Market cap of Bharat Immunological & Biological Corporation Ltd is 74 Cr while Market cap of Source Natural Foods & Herbal Supplements Ltd is 82 Cr

What are the key factors driving the stock performance of Bharat Immunological & Biological Corporation Ltd and Source Natural Foods & Herbal Supplements Ltd?

The stock performance of Bharat Immunological & Biological Corporation Ltd and Source Natural Foods & Herbal Supplements Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Bharat Immunological & Biological Corporation Ltd and Source Natural Foods & Herbal Supplements Ltd?

As of May 6, 2026, the Bharat Immunological & Biological Corporation Ltd stock price is INR ₹17.3. On the other hand, Source Natural Foods & Herbal Supplements Ltd stock price is INR ₹128.05.

How do dividend payouts of Bharat Immunological & Biological Corporation Ltd and Source Natural Foods & Herbal Supplements Ltd compare?

To compare the dividend payouts of Bharat Immunological & Biological Corporation Ltd and Source Natural Foods & Herbal Supplements Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.